Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival

BACKGROUND. From 1988 to 1999, the Radiation Therapy Oncology Group (RTOG) conducted four prospective studies (8802, 8903, 9506, 9706) of patients with clinical stage T2–4a muscle-invasive bladder cancer. Treatment was selective bladder preservation using transurethral surgery (TURBT) plus cisplatin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lautenschlaeger, Tim, George, Asha, Klimowicz, Alexander C., Efstathiou, Jason A., Wu, Chin-Lee, Sandler, Howard, Shipley, William U., Tester, William J., Hagan, Michael P., Magliocco, Anthony M., Chakravarti, Arnab
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2013
Aiheet:
Clinical Trial Results
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063394/
https://ncbi.nlm.nih.gov/pubmed/23728940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0461
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia